Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
13,253
archived clinical trials in
Arthritis

Juvenile Idiopathic Arthritis (JIA) Registry
A Long-term, Multi-center, Longitudinal Post-marketing, Observational Study to Assess Long Term Safety and Effectiveness of HUMIRA® (Adalimumab) in Children With Moderately to Severely Active Polyarticular or Polyarticular-course Juvenile Idiopathic Arthritis (JIA) - STRIVE
Status: Enrolling
Updated:  12/31/1969
Methodist Medical Group Rheum /ID# 46343
mi
from
Peoria, IL
Juvenile Idiopathic Arthritis (JIA) Registry
A Long-term, Multi-center, Longitudinal Post-marketing, Observational Study to Assess Long Term Safety and Effectiveness of HUMIRA® (Adalimumab) in Children With Moderately to Severely Active Polyarticular or Polyarticular-course Juvenile Idiopathic Arthritis (JIA) - STRIVE
Status: Enrolling
Updated: 12/31/1969
Methodist Medical Group Rheum /ID# 46343
mi
from
Peoria, IL
Click here to add this to my saved trials
Juvenile Idiopathic Arthritis (JIA) Registry
A Long-term, Multi-center, Longitudinal Post-marketing, Observational Study to Assess Long Term Safety and Effectiveness of HUMIRA® (Adalimumab) in Children With Moderately to Severely Active Polyarticular or Polyarticular-course Juvenile Idiopathic Arthritis (JIA) - STRIVE
Status: Enrolling
Updated:  12/31/1969
Indiana University /ID# 11421
mi
from
Indianapolis, IN
Juvenile Idiopathic Arthritis (JIA) Registry
A Long-term, Multi-center, Longitudinal Post-marketing, Observational Study to Assess Long Term Safety and Effectiveness of HUMIRA® (Adalimumab) in Children With Moderately to Severely Active Polyarticular or Polyarticular-course Juvenile Idiopathic Arthritis (JIA) - STRIVE
Status: Enrolling
Updated: 12/31/1969
Indiana University /ID# 11421
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Juvenile Idiopathic Arthritis (JIA) Registry
A Long-term, Multi-center, Longitudinal Post-marketing, Observational Study to Assess Long Term Safety and Effectiveness of HUMIRA® (Adalimumab) in Children With Moderately to Severely Active Polyarticular or Polyarticular-course Juvenile Idiopathic Arthritis (JIA) - STRIVE
Status: Enrolling
Updated:  12/31/1969
University of Louisville /ID# 23507
mi
from
Louisville, KY
Juvenile Idiopathic Arthritis (JIA) Registry
A Long-term, Multi-center, Longitudinal Post-marketing, Observational Study to Assess Long Term Safety and Effectiveness of HUMIRA® (Adalimumab) in Children With Moderately to Severely Active Polyarticular or Polyarticular-course Juvenile Idiopathic Arthritis (JIA) - STRIVE
Status: Enrolling
Updated: 12/31/1969
University of Louisville /ID# 23507
mi
from
Louisville, KY
Click here to add this to my saved trials
Juvenile Idiopathic Arthritis (JIA) Registry
A Long-term, Multi-center, Longitudinal Post-marketing, Observational Study to Assess Long Term Safety and Effectiveness of HUMIRA® (Adalimumab) in Children With Moderately to Severely Active Polyarticular or Polyarticular-course Juvenile Idiopathic Arthritis (JIA) - STRIVE
Status: Enrolling
Updated:  12/31/1969
Arthritis Care Spec. of MD /ID# 21961
mi
from
Ellicott City, MD
Juvenile Idiopathic Arthritis (JIA) Registry
A Long-term, Multi-center, Longitudinal Post-marketing, Observational Study to Assess Long Term Safety and Effectiveness of HUMIRA® (Adalimumab) in Children With Moderately to Severely Active Polyarticular or Polyarticular-course Juvenile Idiopathic Arthritis (JIA) - STRIVE
Status: Enrolling
Updated: 12/31/1969
Arthritis Care Spec. of MD /ID# 21961
mi
from
Ellicott City, MD
Click here to add this to my saved trials
Juvenile Idiopathic Arthritis (JIA) Registry
A Long-term, Multi-center, Longitudinal Post-marketing, Observational Study to Assess Long Term Safety and Effectiveness of HUMIRA® (Adalimumab) in Children With Moderately to Severely Active Polyarticular or Polyarticular-course Juvenile Idiopathic Arthritis (JIA) - STRIVE
Status: Enrolling
Updated:  12/31/1969
Tufts Medical Center /ID# 21965
mi
from
Boston, MA
Juvenile Idiopathic Arthritis (JIA) Registry
A Long-term, Multi-center, Longitudinal Post-marketing, Observational Study to Assess Long Term Safety and Effectiveness of HUMIRA® (Adalimumab) in Children With Moderately to Severely Active Polyarticular or Polyarticular-course Juvenile Idiopathic Arthritis (JIA) - STRIVE
Status: Enrolling
Updated: 12/31/1969
Tufts Medical Center /ID# 21965
mi
from
Boston, MA
Click here to add this to my saved trials
Juvenile Idiopathic Arthritis (JIA) Registry
A Long-term, Multi-center, Longitudinal Post-marketing, Observational Study to Assess Long Term Safety and Effectiveness of HUMIRA® (Adalimumab) in Children With Moderately to Severely Active Polyarticular or Polyarticular-course Juvenile Idiopathic Arthritis (JIA) - STRIVE
Status: Enrolling
Updated:  12/31/1969
Creighton University Medical Center /ID# 11423
mi
from
Omaha, NE
Juvenile Idiopathic Arthritis (JIA) Registry
A Long-term, Multi-center, Longitudinal Post-marketing, Observational Study to Assess Long Term Safety and Effectiveness of HUMIRA® (Adalimumab) in Children With Moderately to Severely Active Polyarticular or Polyarticular-course Juvenile Idiopathic Arthritis (JIA) - STRIVE
Status: Enrolling
Updated: 12/31/1969
Creighton University Medical Center /ID# 11423
mi
from
Omaha, NE
Click here to add this to my saved trials
Juvenile Idiopathic Arthritis (JIA) Registry
A Long-term, Multi-center, Longitudinal Post-marketing, Observational Study to Assess Long Term Safety and Effectiveness of HUMIRA® (Adalimumab) in Children With Moderately to Severely Active Polyarticular or Polyarticular-course Juvenile Idiopathic Arthritis (JIA) - STRIVE
Status: Enrolling
Updated:  12/31/1969
St. Barnabas Ambulatory Care /ID# 21025
mi
from
West Orange, NJ
Juvenile Idiopathic Arthritis (JIA) Registry
A Long-term, Multi-center, Longitudinal Post-marketing, Observational Study to Assess Long Term Safety and Effectiveness of HUMIRA® (Adalimumab) in Children With Moderately to Severely Active Polyarticular or Polyarticular-course Juvenile Idiopathic Arthritis (JIA) - STRIVE
Status: Enrolling
Updated: 12/31/1969
St. Barnabas Ambulatory Care /ID# 21025
mi
from
West Orange, NJ
Click here to add this to my saved trials
Juvenile Idiopathic Arthritis (JIA) Registry
A Long-term, Multi-center, Longitudinal Post-marketing, Observational Study to Assess Long Term Safety and Effectiveness of HUMIRA® (Adalimumab) in Children With Moderately to Severely Active Polyarticular or Polyarticular-course Juvenile Idiopathic Arthritis (JIA) - STRIVE
Status: Enrolling
Updated:  12/31/1969
North Shore University Hospital /ID# 21022
mi
from
New Hyde Park, NY
Juvenile Idiopathic Arthritis (JIA) Registry
A Long-term, Multi-center, Longitudinal Post-marketing, Observational Study to Assess Long Term Safety and Effectiveness of HUMIRA® (Adalimumab) in Children With Moderately to Severely Active Polyarticular or Polyarticular-course Juvenile Idiopathic Arthritis (JIA) - STRIVE
Status: Enrolling
Updated: 12/31/1969
North Shore University Hospital /ID# 21022
mi
from
New Hyde Park, NY
Click here to add this to my saved trials
Juvenile Idiopathic Arthritis (JIA) Registry
A Long-term, Multi-center, Longitudinal Post-marketing, Observational Study to Assess Long Term Safety and Effectiveness of HUMIRA® (Adalimumab) in Children With Moderately to Severely Active Polyarticular or Polyarticular-course Juvenile Idiopathic Arthritis (JIA) - STRIVE
Status: Enrolling
Updated:  12/31/1969
University of Rochester Medical Center /ID# 20967
mi
from
Rochester, NY
Juvenile Idiopathic Arthritis (JIA) Registry
A Long-term, Multi-center, Longitudinal Post-marketing, Observational Study to Assess Long Term Safety and Effectiveness of HUMIRA® (Adalimumab) in Children With Moderately to Severely Active Polyarticular or Polyarticular-course Juvenile Idiopathic Arthritis (JIA) - STRIVE
Status: Enrolling
Updated: 12/31/1969
University of Rochester Medical Center /ID# 20967
mi
from
Rochester, NY
Click here to add this to my saved trials
Juvenile Idiopathic Arthritis (JIA) Registry
A Long-term, Multi-center, Longitudinal Post-marketing, Observational Study to Assess Long Term Safety and Effectiveness of HUMIRA® (Adalimumab) in Children With Moderately to Severely Active Polyarticular or Polyarticular-course Juvenile Idiopathic Arthritis (JIA) - STRIVE
Status: Enrolling
Updated:  12/31/1969
New York Medical College /ID# 21964
mi
from
Valhalla, NY
Juvenile Idiopathic Arthritis (JIA) Registry
A Long-term, Multi-center, Longitudinal Post-marketing, Observational Study to Assess Long Term Safety and Effectiveness of HUMIRA® (Adalimumab) in Children With Moderately to Severely Active Polyarticular or Polyarticular-course Juvenile Idiopathic Arthritis (JIA) - STRIVE
Status: Enrolling
Updated: 12/31/1969
New York Medical College /ID# 21964
mi
from
Valhalla, NY
Click here to add this to my saved trials
Juvenile Idiopathic Arthritis (JIA) Registry
A Long-term, Multi-center, Longitudinal Post-marketing, Observational Study to Assess Long Term Safety and Effectiveness of HUMIRA® (Adalimumab) in Children With Moderately to Severely Active Polyarticular or Polyarticular-course Juvenile Idiopathic Arthritis (JIA) - STRIVE
Status: Enrolling
Updated:  12/31/1969
Duke Univ Med Ctr /ID# 22904
mi
from
Durham, NC
Juvenile Idiopathic Arthritis (JIA) Registry
A Long-term, Multi-center, Longitudinal Post-marketing, Observational Study to Assess Long Term Safety and Effectiveness of HUMIRA® (Adalimumab) in Children With Moderately to Severely Active Polyarticular or Polyarticular-course Juvenile Idiopathic Arthritis (JIA) - STRIVE
Status: Enrolling
Updated: 12/31/1969
Duke Univ Med Ctr /ID# 22904
mi
from
Durham, NC
Click here to add this to my saved trials
Juvenile Idiopathic Arthritis (JIA) Registry
A Long-term, Multi-center, Longitudinal Post-marketing, Observational Study to Assess Long Term Safety and Effectiveness of HUMIRA® (Adalimumab) in Children With Moderately to Severely Active Polyarticular or Polyarticular-course Juvenile Idiopathic Arthritis (JIA) - STRIVE
Status: Enrolling
Updated:  12/31/1969
Bone Spine Sports/Medctr One /ID# 21962
mi
from
Bismarck, ND
Juvenile Idiopathic Arthritis (JIA) Registry
A Long-term, Multi-center, Longitudinal Post-marketing, Observational Study to Assess Long Term Safety and Effectiveness of HUMIRA® (Adalimumab) in Children With Moderately to Severely Active Polyarticular or Polyarticular-course Juvenile Idiopathic Arthritis (JIA) - STRIVE
Status: Enrolling
Updated: 12/31/1969
Bone Spine Sports/Medctr One /ID# 21962
mi
from
Bismarck, ND
Click here to add this to my saved trials
Juvenile Idiopathic Arthritis (JIA) Registry
A Long-term, Multi-center, Longitudinal Post-marketing, Observational Study to Assess Long Term Safety and Effectiveness of HUMIRA® (Adalimumab) in Children With Moderately to Severely Active Polyarticular or Polyarticular-course Juvenile Idiopathic Arthritis (JIA) - STRIVE
Status: Enrolling
Updated:  12/31/1969
Akron Childrens Hospital /ID# 22907
mi
from
Akron, OH
Juvenile Idiopathic Arthritis (JIA) Registry
A Long-term, Multi-center, Longitudinal Post-marketing, Observational Study to Assess Long Term Safety and Effectiveness of HUMIRA® (Adalimumab) in Children With Moderately to Severely Active Polyarticular or Polyarticular-course Juvenile Idiopathic Arthritis (JIA) - STRIVE
Status: Enrolling
Updated: 12/31/1969
Akron Childrens Hospital /ID# 22907
mi
from
Akron, OH
Click here to add this to my saved trials
Juvenile Idiopathic Arthritis (JIA) Registry
A Long-term, Multi-center, Longitudinal Post-marketing, Observational Study to Assess Long Term Safety and Effectiveness of HUMIRA® (Adalimumab) in Children With Moderately to Severely Active Polyarticular or Polyarticular-course Juvenile Idiopathic Arthritis (JIA) - STRIVE
Status: Enrolling
Updated:  12/31/1969
University of Cincinnati /ID# 14101
mi
from
Cincinnati, OH
Juvenile Idiopathic Arthritis (JIA) Registry
A Long-term, Multi-center, Longitudinal Post-marketing, Observational Study to Assess Long Term Safety and Effectiveness of HUMIRA® (Adalimumab) in Children With Moderately to Severely Active Polyarticular or Polyarticular-course Juvenile Idiopathic Arthritis (JIA) - STRIVE
Status: Enrolling
Updated: 12/31/1969
University of Cincinnati /ID# 14101
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Juvenile Idiopathic Arthritis (JIA) Registry
A Long-term, Multi-center, Longitudinal Post-marketing, Observational Study to Assess Long Term Safety and Effectiveness of HUMIRA® (Adalimumab) in Children With Moderately to Severely Active Polyarticular or Polyarticular-course Juvenile Idiopathic Arthritis (JIA) - STRIVE
Status: Enrolling
Updated:  12/31/1969
Nationwide Childrens Hospital /ID# 21963
mi
from
Columbus, OH
Juvenile Idiopathic Arthritis (JIA) Registry
A Long-term, Multi-center, Longitudinal Post-marketing, Observational Study to Assess Long Term Safety and Effectiveness of HUMIRA® (Adalimumab) in Children With Moderately to Severely Active Polyarticular or Polyarticular-course Juvenile Idiopathic Arthritis (JIA) - STRIVE
Status: Enrolling
Updated: 12/31/1969
Nationwide Childrens Hospital /ID# 21963
mi
from
Columbus, OH
Click here to add this to my saved trials
Juvenile Idiopathic Arthritis (JIA) Registry
A Long-term, Multi-center, Longitudinal Post-marketing, Observational Study to Assess Long Term Safety and Effectiveness of HUMIRA® (Adalimumab) in Children With Moderately to Severely Active Polyarticular or Polyarticular-course Juvenile Idiopathic Arthritis (JIA) - STRIVE
Status: Enrolling
Updated:  12/31/1969
Legacy Emanuel Child Hosp /ID# 14102
mi
from
Portland, OR
Juvenile Idiopathic Arthritis (JIA) Registry
A Long-term, Multi-center, Longitudinal Post-marketing, Observational Study to Assess Long Term Safety and Effectiveness of HUMIRA® (Adalimumab) in Children With Moderately to Severely Active Polyarticular or Polyarticular-course Juvenile Idiopathic Arthritis (JIA) - STRIVE
Status: Enrolling
Updated: 12/31/1969
Legacy Emanuel Child Hosp /ID# 14102
mi
from
Portland, OR
Click here to add this to my saved trials
Juvenile Idiopathic Arthritis (JIA) Registry
A Long-term, Multi-center, Longitudinal Post-marketing, Observational Study to Assess Long Term Safety and Effectiveness of HUMIRA® (Adalimumab) in Children With Moderately to Severely Active Polyarticular or Polyarticular-course Juvenile Idiopathic Arthritis (JIA) - STRIVE
Status: Enrolling
Updated:  12/31/1969
St. Christopher's Hospital /ID# 24385
mi
from
Philadelphia, PA
Juvenile Idiopathic Arthritis (JIA) Registry
A Long-term, Multi-center, Longitudinal Post-marketing, Observational Study to Assess Long Term Safety and Effectiveness of HUMIRA® (Adalimumab) in Children With Moderately to Severely Active Polyarticular or Polyarticular-course Juvenile Idiopathic Arthritis (JIA) - STRIVE
Status: Enrolling
Updated: 12/31/1969
St. Christopher's Hospital /ID# 24385
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Juvenile Idiopathic Arthritis (JIA) Registry
A Long-term, Multi-center, Longitudinal Post-marketing, Observational Study to Assess Long Term Safety and Effectiveness of HUMIRA® (Adalimumab) in Children With Moderately to Severely Active Polyarticular or Polyarticular-course Juvenile Idiopathic Arthritis (JIA) - STRIVE
Status: Enrolling
Updated:  12/31/1969
Arthritis Associates, PLLC /ID# 44462
mi
from
Kingsport, TN
Juvenile Idiopathic Arthritis (JIA) Registry
A Long-term, Multi-center, Longitudinal Post-marketing, Observational Study to Assess Long Term Safety and Effectiveness of HUMIRA® (Adalimumab) in Children With Moderately to Severely Active Polyarticular or Polyarticular-course Juvenile Idiopathic Arthritis (JIA) - STRIVE
Status: Enrolling
Updated: 12/31/1969
Arthritis Associates, PLLC /ID# 44462
mi
from
Kingsport, TN
Click here to add this to my saved trials
Juvenile Idiopathic Arthritis (JIA) Registry
A Long-term, Multi-center, Longitudinal Post-marketing, Observational Study to Assess Long Term Safety and Effectiveness of HUMIRA® (Adalimumab) in Children With Moderately to Severely Active Polyarticular or Polyarticular-course Juvenile Idiopathic Arthritis (JIA) - STRIVE
Status: Enrolling
Updated:  12/31/1969
Dr. Ramesh Gupta /ID# 45342
mi
from
Memphis, TN
Juvenile Idiopathic Arthritis (JIA) Registry
A Long-term, Multi-center, Longitudinal Post-marketing, Observational Study to Assess Long Term Safety and Effectiveness of HUMIRA® (Adalimumab) in Children With Moderately to Severely Active Polyarticular or Polyarticular-course Juvenile Idiopathic Arthritis (JIA) - STRIVE
Status: Enrolling
Updated: 12/31/1969
Dr. Ramesh Gupta /ID# 45342
mi
from
Memphis, TN
Click here to add this to my saved trials
Juvenile Idiopathic Arthritis (JIA) Registry
A Long-term, Multi-center, Longitudinal Post-marketing, Observational Study to Assess Long Term Safety and Effectiveness of HUMIRA® (Adalimumab) in Children With Moderately to Severely Active Polyarticular or Polyarticular-course Juvenile Idiopathic Arthritis (JIA) - STRIVE
Status: Enrolling
Updated:  12/31/1969
Scott & White Health Care /ID# 36762
mi
from
Round Rock, TX
Juvenile Idiopathic Arthritis (JIA) Registry
A Long-term, Multi-center, Longitudinal Post-marketing, Observational Study to Assess Long Term Safety and Effectiveness of HUMIRA® (Adalimumab) in Children With Moderately to Severely Active Polyarticular or Polyarticular-course Juvenile Idiopathic Arthritis (JIA) - STRIVE
Status: Enrolling
Updated: 12/31/1969
Scott & White Health Care /ID# 36762
mi
from
Round Rock, TX
Click here to add this to my saved trials
Juvenile Idiopathic Arthritis (JIA) Registry
A Long-term, Multi-center, Longitudinal Post-marketing, Observational Study to Assess Long Term Safety and Effectiveness of HUMIRA® (Adalimumab) in Children With Moderately to Severely Active Polyarticular or Polyarticular-course Juvenile Idiopathic Arthritis (JIA) - STRIVE
Status: Enrolling
Updated:  12/31/1969
University of Utah /ID# 21041
mi
from
Salt Lake City, UT
Juvenile Idiopathic Arthritis (JIA) Registry
A Long-term, Multi-center, Longitudinal Post-marketing, Observational Study to Assess Long Term Safety and Effectiveness of HUMIRA® (Adalimumab) in Children With Moderately to Severely Active Polyarticular or Polyarticular-course Juvenile Idiopathic Arthritis (JIA) - STRIVE
Status: Enrolling
Updated: 12/31/1969
University of Utah /ID# 21041
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Juvenile Idiopathic Arthritis (JIA) Registry
A Long-term, Multi-center, Longitudinal Post-marketing, Observational Study to Assess Long Term Safety and Effectiveness of HUMIRA® (Adalimumab) in Children With Moderately to Severely Active Polyarticular or Polyarticular-course Juvenile Idiopathic Arthritis (JIA) - STRIVE
Status: Enrolling
Updated:  12/31/1969
Children's Speciality Center /ID# 11503
mi
from
Burlington, VT
Juvenile Idiopathic Arthritis (JIA) Registry
A Long-term, Multi-center, Longitudinal Post-marketing, Observational Study to Assess Long Term Safety and Effectiveness of HUMIRA® (Adalimumab) in Children With Moderately to Severely Active Polyarticular or Polyarticular-course Juvenile Idiopathic Arthritis (JIA) - STRIVE
Status: Enrolling
Updated: 12/31/1969
Children's Speciality Center /ID# 11503
mi
from
Burlington, VT
Click here to add this to my saved trials
Juvenile Idiopathic Arthritis (JIA) Registry
A Long-term, Multi-center, Longitudinal Post-marketing, Observational Study to Assess Long Term Safety and Effectiveness of HUMIRA® (Adalimumab) in Children With Moderately to Severely Active Polyarticular or Polyarticular-course Juvenile Idiopathic Arthritis (JIA) - STRIVE
Status: Enrolling
Updated:  12/31/1969
Seattle Children's Hospital /ID# 20968
mi
from
Seattle, WA
Juvenile Idiopathic Arthritis (JIA) Registry
A Long-term, Multi-center, Longitudinal Post-marketing, Observational Study to Assess Long Term Safety and Effectiveness of HUMIRA® (Adalimumab) in Children With Moderately to Severely Active Polyarticular or Polyarticular-course Juvenile Idiopathic Arthritis (JIA) - STRIVE
Status: Enrolling
Updated: 12/31/1969
Seattle Children's Hospital /ID# 20968
mi
from
Seattle, WA
Click here to add this to my saved trials
Juvenile Idiopathic Arthritis (JIA) Registry
A Long-term, Multi-center, Longitudinal Post-marketing, Observational Study to Assess Long Term Safety and Effectiveness of HUMIRA® (Adalimumab) in Children With Moderately to Severely Active Polyarticular or Polyarticular-course Juvenile Idiopathic Arthritis (JIA) - STRIVE
Status: Enrolling
Updated:  12/31/1969
Children's Hospital of Wisconsin /ID# 40226
mi
from
Milwaukee, WI
Juvenile Idiopathic Arthritis (JIA) Registry
A Long-term, Multi-center, Longitudinal Post-marketing, Observational Study to Assess Long Term Safety and Effectiveness of HUMIRA® (Adalimumab) in Children With Moderately to Severely Active Polyarticular or Polyarticular-course Juvenile Idiopathic Arthritis (JIA) - STRIVE
Status: Enrolling
Updated: 12/31/1969
Children's Hospital of Wisconsin /ID# 40226
mi
from
Milwaukee, WI
Click here to add this to my saved trials
Juvenile Idiopathic Arthritis (JIA) Registry
A Long-term, Multi-center, Longitudinal Post-marketing, Observational Study to Assess Long Term Safety and Effectiveness of HUMIRA® (Adalimumab) in Children With Moderately to Severely Active Polyarticular or Polyarticular-course Juvenile Idiopathic Arthritis (JIA) - STRIVE
Status: Enrolling
Updated:  12/31/1969
Womens and Childrens Hospital /ID# 59182
mi
from
Adelaide,
Juvenile Idiopathic Arthritis (JIA) Registry
A Long-term, Multi-center, Longitudinal Post-marketing, Observational Study to Assess Long Term Safety and Effectiveness of HUMIRA® (Adalimumab) in Children With Moderately to Severely Active Polyarticular or Polyarticular-course Juvenile Idiopathic Arthritis (JIA) - STRIVE
Status: Enrolling
Updated: 12/31/1969
Womens and Childrens Hospital /ID# 59182
mi
from
Adelaide,
Click here to add this to my saved trials
Post-Market Study of the 3DKnee™ System
Post-Market Study of the 3DKnee™ System Protocol No. PS -- 700
Status: Enrolling
Updated:  12/31/1969
Center for Excellence
mi
from
Fresno, CA
Post-Market Study of the 3DKnee™ System
Post-Market Study of the 3DKnee™ System Protocol No. PS -- 700
Status: Enrolling
Updated: 12/31/1969
Center for Excellence
mi
from
Fresno, CA
Click here to add this to my saved trials
Post-Market Study of the 3DKnee™ System
Post-Market Study of the 3DKnee™ System Protocol No. PS -- 700
Status: Enrolling
Updated:  12/31/1969
OrthoMaryland
mi
from
Baltimore, MD
Post-Market Study of the 3DKnee™ System
Post-Market Study of the 3DKnee™ System Protocol No. PS -- 700
Status: Enrolling
Updated: 12/31/1969
OrthoMaryland
mi
from
Baltimore, MD
Click here to add this to my saved trials
Post-Market Study of the 3DKnee™ System
Post-Market Study of the 3DKnee™ System Protocol No. PS -- 700
Status: Enrolling
Updated:  12/31/1969
Metro Orthopedics and Sports Therapy
mi
from
Silver Spring, MD
Post-Market Study of the 3DKnee™ System
Post-Market Study of the 3DKnee™ System Protocol No. PS -- 700
Status: Enrolling
Updated: 12/31/1969
Metro Orthopedics and Sports Therapy
mi
from
Silver Spring, MD
Click here to add this to my saved trials
Post-Market Study of the 3DKnee™ System
Post-Market Study of the 3DKnee™ System Protocol No. PS -- 700
Status: Enrolling
Updated:  12/31/1969
Leslie Orthopedics and Sports Medicine
mi
from
Camdenton, MO
Post-Market Study of the 3DKnee™ System
Post-Market Study of the 3DKnee™ System Protocol No. PS -- 700
Status: Enrolling
Updated: 12/31/1969
Leslie Orthopedics and Sports Medicine
mi
from
Camdenton, MO
Click here to add this to my saved trials
Post-Market Study of the 3DKnee™ System
Post-Market Study of the 3DKnee™ System Protocol No. PS -- 700
Status: Enrolling
Updated:  12/31/1969
Texas Center for Joint Replacement
mi
from
Plano, TX
Post-Market Study of the 3DKnee™ System
Post-Market Study of the 3DKnee™ System Protocol No. PS -- 700
Status: Enrolling
Updated: 12/31/1969
Texas Center for Joint Replacement
mi
from
Plano, TX
Click here to add this to my saved trials
Post-Market Study of the 3DKnee™ System
Post-Market Study of the 3DKnee™ System Protocol No. PS -- 700
Status: Enrolling
Updated:  12/31/1969
Longo Orthopedics
mi
from
Scottsdale, AZ
Post-Market Study of the 3DKnee™ System
Post-Market Study of the 3DKnee™ System Protocol No. PS -- 700
Status: Enrolling
Updated: 12/31/1969
Longo Orthopedics
mi
from
Scottsdale, AZ
Click here to add this to my saved trials
Post-Market Study of the 3DKnee™ System
Post-Market Study of the 3DKnee™ System Protocol No. PS -- 700
Status: Enrolling
Updated:  12/31/1969
St. Peter's Bone & Joint Surgery
mi
from
Saint Peters, MO
Post-Market Study of the 3DKnee™ System
Post-Market Study of the 3DKnee™ System Protocol No. PS -- 700
Status: Enrolling
Updated: 12/31/1969
St. Peter's Bone & Joint Surgery
mi
from
Saint Peters, MO
Click here to add this to my saved trials
Post-Market Study of the 3DKnee™ System
Post-Market Study of the 3DKnee™ System Protocol No. PS -- 700
Status: Enrolling
Updated:  12/31/1969
Rimrock Orthopedics
mi
from
Saint George, UT
Post-Market Study of the 3DKnee™ System
Post-Market Study of the 3DKnee™ System Protocol No. PS -- 700
Status: Enrolling
Updated: 12/31/1969
Rimrock Orthopedics
mi
from
Saint George, UT
Click here to add this to my saved trials
Anti-TNF Agents for the Treatment of Rheumatoid Arthritis
A Partially Blinded, Randomized, Multi-Center, Phase IV Trial to Evaluate Mechanism of Action of Anti-TNF Agents in Rheumatoid Arthritis
Status: Enrolling
Updated:  12/31/1969
Yale University School of Medicine
mi
from
New Haven, CT
Anti-TNF Agents for the Treatment of Rheumatoid Arthritis
A Partially Blinded, Randomized, Multi-Center, Phase IV Trial to Evaluate Mechanism of Action of Anti-TNF Agents in Rheumatoid Arthritis
Status: Enrolling
Updated: 12/31/1969
Yale University School of Medicine
mi
from
New Haven, CT
Click here to add this to my saved trials
Anti-TNF Agents for the Treatment of Rheumatoid Arthritis
A Partially Blinded, Randomized, Multi-Center, Phase IV Trial to Evaluate Mechanism of Action of Anti-TNF Agents in Rheumatoid Arthritis
Status: Enrolling
Updated:  12/31/1969
University of Chicago
mi
from
Chicago, IL
Anti-TNF Agents for the Treatment of Rheumatoid Arthritis
A Partially Blinded, Randomized, Multi-Center, Phase IV Trial to Evaluate Mechanism of Action of Anti-TNF Agents in Rheumatoid Arthritis
Status: Enrolling
Updated: 12/31/1969
University of Chicago
mi
from
Chicago, IL
Click here to add this to my saved trials
Anti-TNF Agents for the Treatment of Rheumatoid Arthritis
A Partially Blinded, Randomized, Multi-Center, Phase IV Trial to Evaluate Mechanism of Action of Anti-TNF Agents in Rheumatoid Arthritis
Status: Enrolling
Updated:  12/31/1969
University of Rochester
mi
from
Rochester, NY
Anti-TNF Agents for the Treatment of Rheumatoid Arthritis
A Partially Blinded, Randomized, Multi-Center, Phase IV Trial to Evaluate Mechanism of Action of Anti-TNF Agents in Rheumatoid Arthritis
Status: Enrolling
Updated: 12/31/1969
University of Rochester
mi
from
Rochester, NY
Click here to add this to my saved trials
Anti-TNF Agents for the Treatment of Rheumatoid Arthritis
A Partially Blinded, Randomized, Multi-Center, Phase IV Trial to Evaluate Mechanism of Action of Anti-TNF Agents in Rheumatoid Arthritis
Status: Enrolling
Updated:  12/31/1969
Medical University of South Carolina
mi
from
Charleston, SC
Anti-TNF Agents for the Treatment of Rheumatoid Arthritis
A Partially Blinded, Randomized, Multi-Center, Phase IV Trial to Evaluate Mechanism of Action of Anti-TNF Agents in Rheumatoid Arthritis
Status: Enrolling
Updated: 12/31/1969
Medical University of South Carolina
mi
from
Charleston, SC
Click here to add this to my saved trials
Anti-TNF Agents for the Treatment of Rheumatoid Arthritis
A Partially Blinded, Randomized, Multi-Center, Phase IV Trial to Evaluate Mechanism of Action of Anti-TNF Agents in Rheumatoid Arthritis
Status: Enrolling
Updated:  12/31/1969
University of Alabama
mi
from
Birmingham, AL
Anti-TNF Agents for the Treatment of Rheumatoid Arthritis
A Partially Blinded, Randomized, Multi-Center, Phase IV Trial to Evaluate Mechanism of Action of Anti-TNF Agents in Rheumatoid Arthritis
Status: Enrolling
Updated: 12/31/1969
University of Alabama
mi
from
Birmingham, AL
Click here to add this to my saved trials
Anti-TNF Agents for the Treatment of Rheumatoid Arthritis
A Partially Blinded, Randomized, Multi-Center, Phase IV Trial to Evaluate Mechanism of Action of Anti-TNF Agents in Rheumatoid Arthritis
Status: Enrolling
Updated:  12/31/1969
University of California at San Francisco
mi
from
San Francisco, CA
Anti-TNF Agents for the Treatment of Rheumatoid Arthritis
A Partially Blinded, Randomized, Multi-Center, Phase IV Trial to Evaluate Mechanism of Action of Anti-TNF Agents in Rheumatoid Arthritis
Status: Enrolling
Updated: 12/31/1969
University of California at San Francisco
mi
from
San Francisco, CA
Click here to add this to my saved trials
Anti-TNF Agents for the Treatment of Rheumatoid Arthritis
A Partially Blinded, Randomized, Multi-Center, Phase IV Trial to Evaluate Mechanism of Action of Anti-TNF Agents in Rheumatoid Arthritis
Status: Enrolling
Updated:  12/31/1969
The Feinstein Institute for Medical Research
mi
from
Manhasset, NY
Anti-TNF Agents for the Treatment of Rheumatoid Arthritis
A Partially Blinded, Randomized, Multi-Center, Phase IV Trial to Evaluate Mechanism of Action of Anti-TNF Agents in Rheumatoid Arthritis
Status: Enrolling
Updated: 12/31/1969
The Feinstein Institute for Medical Research
mi
from
Manhasset, NY
Click here to add this to my saved trials
Prospective Multicenter Post Approval Study of the LPS-Flex Mobile Bearing Knee
Prospective Multicenter Post Approval Study of the LPS-Flex Mobile Bearing Knee
Status: Enrolling
Updated:  12/31/1969
Phoenix Clinical Research
mi
from
Tamarac, FL
Prospective Multicenter Post Approval Study of the LPS-Flex Mobile Bearing Knee
Prospective Multicenter Post Approval Study of the LPS-Flex Mobile Bearing Knee
Status: Enrolling
Updated: 12/31/1969
Phoenix Clinical Research
mi
from
Tamarac, FL
Click here to add this to my saved trials
Prospective Multicenter Post Approval Study of the LPS-Flex Mobile Bearing Knee
Prospective Multicenter Post Approval Study of the LPS-Flex Mobile Bearing Knee
Status: Enrolling
Updated:  12/31/1969
Tennessee Orthopaedic Foundation for Education and Research
mi
from
Knoxville, TN
Prospective Multicenter Post Approval Study of the LPS-Flex Mobile Bearing Knee
Prospective Multicenter Post Approval Study of the LPS-Flex Mobile Bearing Knee
Status: Enrolling
Updated: 12/31/1969
Tennessee Orthopaedic Foundation for Education and Research
mi
from
Knoxville, TN
Click here to add this to my saved trials
Prospective Multicenter Post Approval Study of the LPS-Flex Mobile Bearing Knee
Prospective Multicenter Post Approval Study of the LPS-Flex Mobile Bearing Knee
Status: Enrolling
Updated:  12/31/1969
Advanced Orthopaedics
mi
from
Auburn Hills, MI
Prospective Multicenter Post Approval Study of the LPS-Flex Mobile Bearing Knee
Prospective Multicenter Post Approval Study of the LPS-Flex Mobile Bearing Knee
Status: Enrolling
Updated: 12/31/1969
Advanced Orthopaedics
mi
from
Auburn Hills, MI
Click here to add this to my saved trials
An Open-label Extension Study of Canakinumab in Patients With Systemic Juvenile Idiopathic Arthritis and Active Systemic Manifestations Manifestations and Response Characterization Study in Canakinumab Treatment-naïve Patients With Active SJIA With and Without Fever.
An Open-label Extension Study of Canakinumab (ACZ885) in Patients With Systemic Juvenile Idiopathic Arthritis (SJIA) and Active Systemic Manifestations Who Participated in Studies ACZ885G2301 and ACZ885G2305; and Response Characterization Study in Canakinumab Treatment-naïve Patients With Active SJIA With and Without Fever
Status: Enrolling
Updated:  12/31/1969
Novartis Investigative site
mi
from
Los Angeles, CA
An Open-label Extension Study of Canakinumab in Patients With Systemic Juvenile Idiopathic Arthritis and Active Systemic Manifestations Manifestations and Response Characterization Study in Canakinumab Treatment-naïve Patients With Active SJIA With and Without Fever.
An Open-label Extension Study of Canakinumab (ACZ885) in Patients With Systemic Juvenile Idiopathic Arthritis (SJIA) and Active Systemic Manifestations Who Participated in Studies ACZ885G2301 and ACZ885G2305; and Response Characterization Study in Canakinumab Treatment-naïve Patients With Active SJIA With and Without Fever
Status: Enrolling
Updated: 12/31/1969
Novartis Investigative site
mi
from
Los Angeles, CA
Click here to add this to my saved trials
An Open-label Extension Study of Canakinumab in Patients With Systemic Juvenile Idiopathic Arthritis and Active Systemic Manifestations Manifestations and Response Characterization Study in Canakinumab Treatment-naïve Patients With Active SJIA With and Without Fever.
An Open-label Extension Study of Canakinumab (ACZ885) in Patients With Systemic Juvenile Idiopathic Arthritis (SJIA) and Active Systemic Manifestations Who Participated in Studies ACZ885G2301 and ACZ885G2305; and Response Characterization Study in Canakinumab Treatment-naïve Patients With Active SJIA With and Without Fever
Status: Enrolling
Updated:  12/31/1969
Novartis Investigative Site
mi
from
Louisville, KY
An Open-label Extension Study of Canakinumab in Patients With Systemic Juvenile Idiopathic Arthritis and Active Systemic Manifestations Manifestations and Response Characterization Study in Canakinumab Treatment-naïve Patients With Active SJIA With and Without Fever.
An Open-label Extension Study of Canakinumab (ACZ885) in Patients With Systemic Juvenile Idiopathic Arthritis (SJIA) and Active Systemic Manifestations Who Participated in Studies ACZ885G2301 and ACZ885G2305; and Response Characterization Study in Canakinumab Treatment-naïve Patients With Active SJIA With and Without Fever
Status: Enrolling
Updated: 12/31/1969
Novartis Investigative Site
mi
from
Louisville, KY
Click here to add this to my saved trials
An Open-label Extension Study of Canakinumab in Patients With Systemic Juvenile Idiopathic Arthritis and Active Systemic Manifestations Manifestations and Response Characterization Study in Canakinumab Treatment-naïve Patients With Active SJIA With and Without Fever.
An Open-label Extension Study of Canakinumab (ACZ885) in Patients With Systemic Juvenile Idiopathic Arthritis (SJIA) and Active Systemic Manifestations Who Participated in Studies ACZ885G2301 and ACZ885G2305; and Response Characterization Study in Canakinumab Treatment-naïve Patients With Active SJIA With and Without Fever
Status: Enrolling
Updated:  12/31/1969
Novartis Investigative site
mi
from
Boston, MA
An Open-label Extension Study of Canakinumab in Patients With Systemic Juvenile Idiopathic Arthritis and Active Systemic Manifestations Manifestations and Response Characterization Study in Canakinumab Treatment-naïve Patients With Active SJIA With and Without Fever.
An Open-label Extension Study of Canakinumab (ACZ885) in Patients With Systemic Juvenile Idiopathic Arthritis (SJIA) and Active Systemic Manifestations Who Participated in Studies ACZ885G2301 and ACZ885G2305; and Response Characterization Study in Canakinumab Treatment-naïve Patients With Active SJIA With and Without Fever
Status: Enrolling
Updated: 12/31/1969
Novartis Investigative site
mi
from
Boston, MA
Click here to add this to my saved trials
An Open-label Extension Study of Canakinumab in Patients With Systemic Juvenile Idiopathic Arthritis and Active Systemic Manifestations Manifestations and Response Characterization Study in Canakinumab Treatment-naïve Patients With Active SJIA With and Without Fever.
An Open-label Extension Study of Canakinumab (ACZ885) in Patients With Systemic Juvenile Idiopathic Arthritis (SJIA) and Active Systemic Manifestations Who Participated in Studies ACZ885G2301 and ACZ885G2305; and Response Characterization Study in Canakinumab Treatment-naïve Patients With Active SJIA With and Without Fever
Status: Enrolling
Updated:  12/31/1969
Novartis Investigative Site
mi
from
Cincinnati, OH
An Open-label Extension Study of Canakinumab in Patients With Systemic Juvenile Idiopathic Arthritis and Active Systemic Manifestations Manifestations and Response Characterization Study in Canakinumab Treatment-naïve Patients With Active SJIA With and Without Fever.
An Open-label Extension Study of Canakinumab (ACZ885) in Patients With Systemic Juvenile Idiopathic Arthritis (SJIA) and Active Systemic Manifestations Who Participated in Studies ACZ885G2301 and ACZ885G2305; and Response Characterization Study in Canakinumab Treatment-naïve Patients With Active SJIA With and Without Fever
Status: Enrolling
Updated: 12/31/1969
Novartis Investigative Site
mi
from
Cincinnati, OH
Click here to add this to my saved trials
An Open-label Extension Study of Canakinumab in Patients With Systemic Juvenile Idiopathic Arthritis and Active Systemic Manifestations Manifestations and Response Characterization Study in Canakinumab Treatment-naïve Patients With Active SJIA With and Without Fever.
An Open-label Extension Study of Canakinumab (ACZ885) in Patients With Systemic Juvenile Idiopathic Arthritis (SJIA) and Active Systemic Manifestations Who Participated in Studies ACZ885G2301 and ACZ885G2305; and Response Characterization Study in Canakinumab Treatment-naïve Patients With Active SJIA With and Without Fever
Status: Enrolling
Updated:  12/31/1969
Novartis Investigative Site
mi
from
Columbus, OH
An Open-label Extension Study of Canakinumab in Patients With Systemic Juvenile Idiopathic Arthritis and Active Systemic Manifestations Manifestations and Response Characterization Study in Canakinumab Treatment-naïve Patients With Active SJIA With and Without Fever.
An Open-label Extension Study of Canakinumab (ACZ885) in Patients With Systemic Juvenile Idiopathic Arthritis (SJIA) and Active Systemic Manifestations Who Participated in Studies ACZ885G2301 and ACZ885G2305; and Response Characterization Study in Canakinumab Treatment-naïve Patients With Active SJIA With and Without Fever
Status: Enrolling
Updated: 12/31/1969
Novartis Investigative Site
mi
from
Columbus, OH
Click here to add this to my saved trials
An Open-label Extension Study of Canakinumab in Patients With Systemic Juvenile Idiopathic Arthritis and Active Systemic Manifestations Manifestations and Response Characterization Study in Canakinumab Treatment-naïve Patients With Active SJIA With and Without Fever.
An Open-label Extension Study of Canakinumab (ACZ885) in Patients With Systemic Juvenile Idiopathic Arthritis (SJIA) and Active Systemic Manifestations Who Participated in Studies ACZ885G2301 and ACZ885G2305; and Response Characterization Study in Canakinumab Treatment-naïve Patients With Active SJIA With and Without Fever
Status: Enrolling
Updated:  12/31/1969
Novartis
mi
from
Portland, OR
An Open-label Extension Study of Canakinumab in Patients With Systemic Juvenile Idiopathic Arthritis and Active Systemic Manifestations Manifestations and Response Characterization Study in Canakinumab Treatment-naïve Patients With Active SJIA With and Without Fever.
An Open-label Extension Study of Canakinumab (ACZ885) in Patients With Systemic Juvenile Idiopathic Arthritis (SJIA) and Active Systemic Manifestations Who Participated in Studies ACZ885G2301 and ACZ885G2305; and Response Characterization Study in Canakinumab Treatment-naïve Patients With Active SJIA With and Without Fever
Status: Enrolling
Updated: 12/31/1969
Novartis
mi
from
Portland, OR
Click here to add this to my saved trials
An Open-label Extension Study of Canakinumab in Patients With Systemic Juvenile Idiopathic Arthritis and Active Systemic Manifestations Manifestations and Response Characterization Study in Canakinumab Treatment-naïve Patients With Active SJIA With and Without Fever.
An Open-label Extension Study of Canakinumab (ACZ885) in Patients With Systemic Juvenile Idiopathic Arthritis (SJIA) and Active Systemic Manifestations Who Participated in Studies ACZ885G2301 and ACZ885G2305; and Response Characterization Study in Canakinumab Treatment-naïve Patients With Active SJIA With and Without Fever
Status: Enrolling
Updated:  12/31/1969
Novartis Investigative Site
mi
from
Caba,
An Open-label Extension Study of Canakinumab in Patients With Systemic Juvenile Idiopathic Arthritis and Active Systemic Manifestations Manifestations and Response Characterization Study in Canakinumab Treatment-naïve Patients With Active SJIA With and Without Fever.
An Open-label Extension Study of Canakinumab (ACZ885) in Patients With Systemic Juvenile Idiopathic Arthritis (SJIA) and Active Systemic Manifestations Who Participated in Studies ACZ885G2301 and ACZ885G2305; and Response Characterization Study in Canakinumab Treatment-naïve Patients With Active SJIA With and Without Fever
Status: Enrolling
Updated: 12/31/1969
Novartis Investigative Site
mi
from
Caba,
Click here to add this to my saved trials